Case ReportChronic Strongyloidiasis in the Primary Care SettingSy, Hendrik MD; Zalcgendler, Sara MD; Edelman, Deborah MD Author Information From the Department of Medicine, Mount Sinai Morningside-West, Icahn School of Medicine at Mount Sinai, New York, NY. Correspondence to: Hendrik Sy, MD, 1000 Tenth Avenue, New York, NY 10019 10024. E-mail: [email protected]. The authors have no funding or conflicts of interest to disclose. Written informed consent was obtained by the patients described in this case report. All authors contributed substantially to the manuscript and have given their approval to publication. H.S. and D.E. did the direct patient care, manuscript drafting, and coordination of project. S.Z. did the direct patient care and manuscript drafting. Infectious Diseases in Clinical Practice: November 2022 - Volume 30 - Issue 6 - p 1-3 doi: 10.1097/IPC.0000000000001166 Buy Metrics Abstract Strongyloides stercoralis can persist for decades in the human host through autoinfection. It can lead to hyperinfection syndrome, which has a high mortality rate and is associated with corticosteroid use. Twelve patients presented to our primary care clinic in New York with eosinophilia and were found to have chronic strongyloidiasis. The patients' characteristics are summarized and the current literature on screening of strongyloidiasis is reviewed. We aim to increase awareness for this condition among primary care providers that care for immigrant populations, especially with widespread use of corticosteroids for the treatment of coronavirus disease 2019. Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.